
Western Blot (WB) analysis using Flk-1 Monoclonal Antibody against extracellular domain of human Flk-1 (aa20-764).
KDR / VEGFR2 / FLK1 Antibody
Primary AntibodyLSBio Guarantee
| Antibody: | Mouse Monoclonal |
| Applications: | Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence, Western Blot |
| Reactivity: | Human |
| Format: | Liquid |
$339.00each
Catalog Number: LS-C812376-50
Catalog Number: LS-C812376
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- FLK1 antibody LS-C812376 is an unconjugated mouse monoclonal antibody to human FLK1 (KDR / VEGFR2). Validated for ELISA, Flow, IF and WB.
- Application
- ELISA, FC, IF, WB
- Reactivity
- Hu
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Monoclonal Antibodies
- Alternative Names
- CD309 | Fetal liver kinase 1 | Fetal liver kinase-1 | KDR | FLK-1 | FLK1 | Kinase insert domain receptor | Quek1 | VEGFR | VEGFR2 | Soluble VEGFR2 | VEGF receptor 2 | VEGFR-2 | CD309 antigen | VEGF-R2
- Recommended Dilution: ELISA
- 1:10000
- Recommended Dilution: FC
- 1:200 - 1:400
- Recommended Dilution: IF/ICC
- 1:200 - 1:1000
- Recommended Dilution: WB
- 1:500 - 1:2000
- UniProt Number
- P35968
- NCBI GenBank
- NM_002253 | NP_002244.1
- SwissProt
- P35968
Target
- Target
- Human KDR / VEGFR2 / FLK1
- Antigen Species
- Human
- Epitope
- Flk-1 Monoclonal Antibody detects endogenous levels of Flk-1 protein.
- Gene Name
- KDR
Antibody
- Host Species
- Mouse
- Clonality
- Monoclonal
- Isotype
- IgG1
- Origin Species
- Human
Immunogen
- Immunogen
- Purified recombinant extracellular fragment of human Flk-1 (aa20-764) fused with hIgGFc tag expressed in HEK293 cells.
- Immunogen Type
- Recombinant Protein Fragment
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- Purified ascitic fluid, 0.03% sodium azide
- Preservative
- Yes
- Purification Method
- Affinity Purified
Storage & Handling
- Storage Conditions
- Store at -20°C. Avoid freeze-thaw cycles.
